Virtus ETF Advisers LLC Spring Works Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

  • $196 Million
  • Q2 2024

A detailed history of Virtus ETF Advisers LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 8,415 shares of SWTX stock, worth $271,636. This represents 0.16% of its overall portfolio holdings.

Number of Shares
8,415
Previous 10,987 23.41%
Holding current value
$271,636
Previous $540,000 41.48%
% of portfolio
0.16%
Previous 0.3%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$36.06 - $47.62 $92,746 - $122,478
-2,572 Reduced 23.41%
8,415 $316,000
Q1 2024

May 15, 2024
BUY
$36.5 - $52.5 $57,706 - $83,002
1,581 Added 16.81%
10,987 $540,000
Q4 2023

Feb 15, 2024
BUY
$18.94 - $37.24 $110,155 - $216,587
5,816 Added 162.01%
9,406 $343,000
Q3 2023

Nov 07, 2023
SELL
$23.12 - $31.38 $8,230 - $11,171
-356 Reduced 9.02%
3,590 $83,000
Q2 2023

Aug 14, 2023
SELL
$23.15 - $32.71 $8,519 - $12,037
-368 Reduced 8.53%
3,946 $103,000
Q1 2023

May 15, 2023
SELL
$24.97 - $34.05 $41,550 - $56,659
-1,664 Reduced 27.84%
4,314 $111,000
Q4 2022

Feb 14, 2023
BUY
$21.73 - $28.72 $17,970 - $23,751
827 Added 16.06%
5,978 $155,000
Q3 2022

Nov 14, 2022
BUY
$24.1 - $39.66 $964 - $1,586
40 Added 0.78%
5,151 $147,000
Q2 2022

Aug 12, 2022
BUY
$18.36 - $60.07 $51,830 - $169,577
2,823 Added 123.38%
5,111 $126,000
Q1 2022

May 16, 2022
SELL
$48.97 - $65.46 $6,708 - $8,968
-137 Reduced 5.65%
2,288 $129,000
Q4 2021

Feb 14, 2022
SELL
$53.3 - $75.84 $11,459 - $16,305
-215 Reduced 8.14%
2,425 $150,000
Q3 2021

Nov 15, 2021
SELL
$62.66 - $88.26 $8,396 - $11,826
-134 Reduced 4.83%
2,640 $167,000
Q2 2021

Aug 10, 2021
SELL
$67.45 - $85.63 $83,098 - $105,496
-1,232 Reduced 30.75%
2,774 $229,000
Q1 2021

May 17, 2021
BUY
$65.1 - $93.59 $4,296 - $6,176
66 Added 1.68%
4,006 $295,000
Q4 2020

Feb 12, 2021
SELL
$48.36 - $77.92 $156,106 - $251,525
-3,228 Reduced 45.03%
3,940 $286,000
Q3 2020

Nov 13, 2020
SELL
$36.14 - $51.99 $35,453 - $51,002
-981 Reduced 12.04%
7,168 $342,000
Q2 2020

Aug 05, 2020
SELL
$22.98 - $48.57 $98,791 - $208,802
-4,299 Reduced 34.54%
8,149 $342,000
Q1 2020

May 14, 2020
SELL
$20.44 - $41.21 $36,894 - $74,384
-1,805 Reduced 12.66%
12,448 $336,000
Q4 2019

Feb 13, 2020
BUY
$17.74 - $39.52 $252,848 - $563,278
14,253 New
14,253 $549,000

Others Institutions Holding SWTX

# of Institutions
221
Shares Held
66.8M
Call Options Held
64.7K
Put Options Held
150K
View Full List

About SpringWorks Therapeutics, Inc.

SWTX Quotes by TradingView
  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.01B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email